Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative inhaled salbutamol versus placebo to prevent perioperative respiratory adverse events in high-risk children
ACTRN12612000626864Phase 4Completed
- Sponsor
- Princess Margaret Hospital for Children
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of salbutamol in respiratory complication, sponsored by Princess Margaret Hospital for Children. Primary endpoint: Incidence of perioperative respiratory complications. Started Dec 2012; status: completed.
02
Drugs
salbutamol
03
Conditions
respiratory complication
Beyond the preview
Go deeper on ACTRN12612000626864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000626864.